What Is VRAYLAR® (cariprazine)? - Major Depressive Disorder Skip to Main Content VRAYLAR is a prescription medicine used along with antidepressant medicines to treat major depressive disorder (MDD) in adults. VRAYLAR is a prescription medicine used along with antidepressant medicines to treat major depressive disorder (MDD) in adults. VRAYLAR is a prescription medicine used along with antidepressant medicines to treat major depressive disorder (MDD) in adults. SELECT CONDITION Major Depressive Disorder Bipolar I Disorder Other Condition Important Safety Information Prescribing Information Medication Guide Cost & Savings Healthcare Professional Site Sign up for support See savings* About VRAYLAR How could VRAYLAR help? How does VRAYLAR work? How do I take VRAYLAR? Hear from a real VRAYLAR patient What are the possible side effects? Looking for a way to help break through to relief? Managing depression How common is depression? Common depression symptoms Watch real MDD patient stories Depression symptom tracker Understanding treatment options Add-on treatments Support & resources Save on VRAYLAR Track your mood & symptoms Find a support group Share your VRAYLAR story Resources for starting VRAYLAR Faq s Connect with a healthcare provider Sign up for support social fb insta youtube Healthcare Professional site EN ESPAÑOL What is VRAYLAR ? VRAYLAR is approved as an add-on prescription medication for major depressive disorder in adults who are currently taking an antidepressant but still have unresolved depression symptoms. How could VRAYLAR help me? You’ve made progress with your antidepressant, but depressive symptoms may still leave you feeling stuck. Taking VRAYLAR as an add-on for depression may help you break through to relief and may help you get where you want to be. Adding VRAYLAR to an antidepressant is clinically proven to help relieve overall depression symptoms better than an antidepressant alone. In 6- and 8-week studies, † adults, on average, experienced improvement in their overall depression symptoms after adding VRAYLAR to their antidepressant vs an antidepressant alone. † Individual results may vary. Have you ever tried an add-on treatment, along with your antidepressant? Select an answer below to discover options that may be right for you. Yes, but I'd like to learn more about VRAYLAR No, but I'm interested in seeing how VRAYLAR may help No, but I would like to learn more about managing depression Yes, but I'd like to learn more about VRAYLAR How could VRAYLAR help me? Adding VRAYLAR to an antidepressant is clinically proven to help relieve overall depression symptoms better than an antidepressant alone. ‡ See what VRAYLAR can do ‡ Individual results may vary. No, but I’m interested in seeing how VRAYLAR may help How can I start the conversation about VRAYLAR? Answer 3 simple questions to create a personalized discussion guide for your next appointment with your healthcare team. Start now No, but I would like to learn more about managing depression How can I manage my depressive symptoms? Get a refresher on ways to manage depression and how add-on treatments may be able to help. Get insights Reset How does VRAYLAR work? VRAYLAR is a once-daily capsule that is taken with your antidepressant. VRAYLAR works differently than your antidepressant. While the exact way VRAYLAR works is unknown, healthcare providers and scientists believe that VRAYLAR helps regulate dopamine and serotonin in the brain. Watch the video to learn more about how VRAYLAR is thought to work. Transcript View transcript How do I take VRAYLAR? One pill Once a day Taken any time of day With or without food Things to keep in mind when taking VRAYLAR Treatments like VRAYLAR start working gradually . Every patient is different, so it’s important to stick with your treatment plan. VRAYLAR is a once-daily pill that should be taken as directed by your healthcare provider. Although VRAYLAR can be taken at any time of the day, it may help to take VRAYLAR at the same time every day to help build a treatment routine. Do not stop taking VRAYLAR or change how much you take without checking with your healthcare provider first. Hear about Kami’s experience with VRAYLAR Kami was diagnosed with major depressive disorder. Even though she was taking an antidepressant, she still struggled with lingering depression symptoms. Watch Kami's story and see her experience with adding VRAYLAR to her antidepressant to help manage her depression symptoms. The person featured in this video is sharing her individual experience with VRAYLAR. Individual experiences with the condition and treatment will vary. Talk to your healthcare provider to see if VRAYLAR may be right for you. Transcript View transcript What antidepressants could I take with VRAYLAR? Examples of common antidepressants that were taken with VRAYLAR in the clinical studies ‡§ : SSRI antidepressants Prozac ® (fluoxetine) Paxil ® (paroxetine) Zoloft ® (sertraline) SNRI antidepressants Cymbalta ® (duloxetine) Effexor ® (venlafaxine) NDRI antidepressant Wellbutrin ® (bupropion hydrochloride) SSRI=selective serotonin reuptake inhibitor; SNRI=serotonin and norepinephrine reuptake inhibitor; NDRI=norepinephrine and dopamine reuptake inhibitor. ‡ These are not all the antidepressants studied with VRAYLAR. Ask your healthcare provider if adding VRAYLAR is right for you. § All trademarks are property of their respective owners. What are some of the possible side effects of VRAYLAR? The most common side effects include difficulty moving or slow movements, tremors, uncontrolled body movements, restlessness and feeling like you need to move around, sleepiness, nausea, vomiting, indigestion (upset stomach), constipation, feeling tired, trouble sleeping, increased appetite, and dizziness. Tell your healthcare provider if you have any side effect that bothers you or that does not go away. These are not all the possible side effects of VRAYLAR. Please see below for additional safety information. Does VRAYLAR cause weight gain? Most people taking VRAYLAR + antidepressant (ADT) saw no substantial impact on weight. Average weight change in 6-week major depressive disorder studies: In clinical studies, 98% of patients in 6-week trials and 81% of patients in a 6-month trial had no substantial weight gain (defined by ≥7% change). In the 6-month study, the average weight gain in VRAYLAR-treated patients was 3.7 lb. Weight gain may occur. You and your doctor should monitor your weight regularly. || VRAYLAR 1.5 mg/day and 3.0 mg/day. ADT=antidepressant. Can I anticipate any sexual side effects when adding VRAYLAR? In clinical studies, less than 1% of patients taking VRAYLAR with their antidepressant reported sexual side effects ¶ Placebo + ADT (n=503) VRAYLAR 1.5 mg/day + ADT (n=502) VRAYLAR 3 mg/day + ADT (n=503) Abnormal orgasm 0% 0% 0.2% Decreased sex drive 0% 0.2% 0% Erectile dysfunction 0% 0.2% 0% Ejaculation failure 0% 0.2% 0% Ejaculation disorder 0% 0% 0% ¶ These adverse events were self-reported by patients in 6-week studies. Test your knowledge: myth or fact? Do you know the truth about depression and its treatments? Choose whether the statements are myths or facts. Myth or Fact Men don’t typically get depression. Myth Fact Depression affects people of all genders and should be taken seriously by everyone. The stigma surrounding depression can discourage people of any gender from getting the help they need. Myth or Fact An add-on treatment replaces your antidepressant. Myth Fact Add-on depression treatments do not replace your antidepressant. They are designed to work with your antidepressant to help relieve your depression symptoms. Myth or Fact The only way to manage depression is with an antidepressant. Myth Fact There are several options that can be effective at managing depression, even when you feel stuck. It’s important to work with your healthcare team to find the treatment(s)—medication, therapy, and lifestyle changes—that work for you. Breaking through to relief is possible Watch our TV ad and ask your provider if adding VRAYLAR to your antidepressant can help you break through to relief. View transcript Watch Now View transcript Watch Now Ready to share your VRAYLAR story? Have you taken VRAYLAR and want to tell your story? Just call 347-305-1330 347-305-1330 or email patientengagement@healthcentral.com Everyone’s journey with depression is different. Get helpful resources and support to help you stay on track with your prescribed treatment plan. Find support & resources Find support & resources Additional Resources Make the most out of your appointment Help your provider understand how you’re feeling. Complete this simple quiz about your symptoms to create a personalized discussion guide for your next appointment. Take quiz Get to know VRAYLAR Learn how VRAYLAR is thought to work, who it’s for, why you might consider it, and more. Download the brochure Find a healthcare provider Use this tool to find a healthcare provider in your area and create a reminder for your next appointment. Search near you *Terms and conditions apply. Available to commercially insured patients only. See Terms and Conditions for full details. INDICATION AND USAGE VRAYLAR is a prescription medicine used along with antidepressant medicines to treat major depressive disorder (MDD) in adults. IMPORTANT SAFETY INFORMATION What is the most important information I should know about VRAYLAR? Elderly people with dementia-related psychosis (having lost touch with reality due to confusion and memory loss) taking medicines like VRAYLAR are at an increased risk of death. VRAYLAR is not approved for treating patients with dementia-related psychosis. VRAYLAR and antidepressants increase the risk of suicidal thoughts or actions in people 24 years of age and younger especially within the first few months of treatment or when the dose is changed. Depression and other mental illnesses are the most important causes of suicidal thoughts and actions. Patients on antidepressants and their families or caregivers should watch for new or worsening depression symptoms, especially sudden changes in mood, behaviors, thoughts, or feelings. This is very important when VRAYLAR or the antidepressant is started or when the dose is changed. Report any change in these symptoms immediately to the doctor. VRAYLAR may cause serious side effects, including: Stroke (cerebrovascular problems) in elderly people with dementia-related psychosis that can lead to death Neuroleptic malignant syndrome (NMS): Call your healthcare provider or go to the nearest hospital emergency room right away if you have high fever, stiff muscles, confusion, increased sweating, or changes in breathing, heart rate, and blood pressure. These can be symptoms of a rare but potentially fatal side effect called NMS. VRAYLAR should be stopped if you have NMS. Uncontrolled body movements (tardive dyskinesia or TD): VRAYLAR may cause movements that you cannot control in your face, tongue, or other body parts. Tardive dyskinesia may not go away, even if you stop taking VRAYLAR. Tardive dyskinesia may also start after you stop taking VRAYLAR. Late-occurring side effects: VRAYLAR stays in your body for a long time. Some side effects may not happen right away and can start a few weeks after starting VRAYLAR, or if your dose increases. Your healthcare provider should monitor you for side effects for several weeks after starting or increasing dose of VRAYLAR. Problems with your metabolism, such as: High blood sugar and diabetes: Increases in blood sugar can happen in some people who take VRAYLAR. Extremely high blood sugar can lead to coma or death. Your healthcare provider should check your blood sugar before or soon after starting VRAYLAR and regularly during treatment. Tell your healthcare provider if you have symptoms such as feeling very thirsty, very hungry, or sick to your stomach, urinating more than usual, feeling weak, tired, confused, or your breath smells fruity. Increased fat levels (cholesterol and triglycerides) in your blood: Your healthcare provider should check fat levels in your blood before or soon after starting VRAYLAR and during treatment. Weight gain: Weight gain has been reported with VRAYLAR. You and your healthcare provider should check your weight before and regularly during treatment. Low white blood cell count: Low white blood cell counts have been reported with antipsychotic drugs, including VRAYLAR. This may increase your risk of infection. Very low white blood cell counts, which can be fatal, have been reported with other antipsychotics. Your healthcare provider may do blood tests during the first few months of treatment with VRAYLAR. Decreased blood pressure (orthostatic hypotension): You may feel lightheaded or faint when you rise too quickly from a sitting or lying position. Falls: VRAYLAR may make you sleepy or dizzy, may cause a decrease in blood pressure when changing position (orthostatic hypotension), and can slow thinking and motor skills, which may lead to falls that can cause fractures or other injuries. Seizures (convulsions) Sleepiness, drowsiness, feeling tired, difficulty thinking and doing normal activities: Do NOT drive, operate machinery, or do other dangerous activities until you know how VRAYLAR affects you. VRAYLAR may make you drowsy. Increased body temperature: Do not become too hot or dehydrated during VRAYLAR treatment. Do not exercise too much. In hot weather, stay inside in a cool place if possible. Stay out of the sun. Do not wear too much clothing or heavy clothing. Drink plenty of water. Difficulty swallowing that can cause food or liquid to get into your lungs Who should not take VRAYLAR? Do not take VRAYLAR if you are allergic to any of its ingredients. Get emergency medical help if you are having an allergic reaction (eg, rash, itching, hives, swelling of the tongue, lip, face or throat). What should I tell my healthcare provider before taking VRAYLAR? Tell your healthcare provider about any medical conditions and if you: have or had heart problems or a stroke have or had low or high blood pressure have or had diabetes or high blood sugar in you or your family have or had high levels of total cholesterol, LDL-cholesterol, or triglycerides; or low levels of HDL-cholesterol have or had seizures (convulsions) have or had kidney or liver problems have or had low white blood cell count are pregnant or plan to become pregnant. VRAYLAR may harm your unborn baby. Taking VRAYLAR during your third trimester of pregnancy may cause your baby to have abnormal muscle movements or withdrawal symptoms after birth. Talk to your healthcare provider about the risk to your unborn baby if you take VRAYLAR during pregnancy. There is a pregnancy exposure registry for women who are exposed to VRAYLAR during pregnancy. If you become pregnant or think you are pregnant during treatment, talk to your healthcare provider about registering with the National Pregnancy Registry for Atypical Antipsychotics at 1-866-961-2388 or http://www.womensmentalhealth.org/clinical-and-research-programs/pregnancyregistry/ . are breastfeeding or plan to breastfeed. It is not known if VRAYLAR passes into breast milk. Talk to your healthcare provider about the best way to feed your baby during treatment with VRAYLAR. Tell your healthcare provider about all medicines that you take, including prescriptions, over-the-counter medicines, vitamins, and supplements. VRAYLAR may affect the way other medicines work, and other medicines may affect how VRAYLAR works. Do not start or stop any medicines while taking VRAYLAR without talking to your healthcare provider. What are the most common side effects of VRAYLAR? The most common side effects include difficulty moving or slow movements, tremors, uncontrolled body movements, restlessness and feeling like you need to move around, sleepiness, nausea, vomiting, indigestion, constipation, feeling tired, trouble sleeping, increased appetite, and dizziness. These are not all the possible side effects of VRAYLAR. VRAYLAR is available in 0.5 mg, 0.75 mg, 1.5 mg, 3 mg, 4.5 mg, and 6 mg capsules. INDICATIONS AND USAGE VRAYLAR is a prescription medicine used: along with antidepressant medicines to treat major depressive disorder (MDD) in adults to treat depressive episodes that happen with bipolar I disorder (bipolar depression) in adults to treat short-term (acute) manic or mixed episodes that happen with bipolar I disorder in adults and children ages 10 years and older Please see the full Prescribing Information , including Boxed Warnings, and Medication Guide . US-VRAA-250457 You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088. If you are having difficulty paying for your medicine, AbbVie may be able to help. Visit AbbVie.com/myAbbVieAssist to learn more. HOME ABOUT ABBVIE PRESCRIBING INFORMATION SITE MAP ACCESSIBILITY STATEMENT CONTACT US TERMS OF USE PRIVACY NOTICE COOKIES SETTINGS YOUR PRIVACY CHOICES THIS SITE IS INTENDED FOR U.S. CONSUMERS ONLY. LICENSED FROM GEDEON RICHTER PLC. © 2025 ABBVIE. ALL RIGHTS RESERVED. VRAYLAR ® AND ITS DESIGN ARE TRADEMARKS OF ALLERGAN PHARMACEUTICALS INTERNATIONAL LIMITED, AN ABBVIE COMPANY. VRAYPAY IS A SERVICE MARK OF ALLERGAN PHARMACEUTICALS INTERNATIONAL LIMITED, AN ABBVIE COMPANY. IF YOU ARE A PATIENT, AND HAVE ANY QUESTIONS, PLEASE DISCUSS THEM WITH YOUR DOCTOR OR HEALTHCARE PROVIDER. FOR ADDITIONAL INFORMATION ABOUT VRAYLAR ® , CALL ABBVIE MEDICAL INFORMATION TOLL-FREE AT 1.800.678.1605. US-VRAA-250361 Looking for a Lift in Relief Transcript View transcript Looking for a Lift in Relief Transcript View transcript Breaking through to relief is possible Transcript View transcript Breaking through to relief is possible Transcript View transcript You are now leaving VRAYLAR.com You are leaving the VRAYLAR (cariprazine) site and connecting to a site that is not under the control of AbbVie. AbbVie is not responsible for the contents of any such site or any further links from such site. AbbVie is providing these links to you only as a convenience and the inclusion of any link does not imply the endorsement of the linked site by AbbVie. You should also be aware that the linked site may be governed by its own set of terms and conditions and privacy policy for which AbbVie has no responsibility. Conversely, the presence of this link does not imply the linked site's endorsement of VRAYLAR.com or AbbVie. Do you wish to leave this site? YES NO US-VRAA-230191 You are now leaving VRAYLAR.com Links to other websites are provided as a service to you. AbbVie accepts no responsibility for the content of other sites. Would you like to continue? YES NO US-VRAA-220054 You are now leaving VRAYLAR.com Links to other websites are provided as a service to you. AbbVie accepts no responsibility for the content of other sites. Would you like to continue? YES NO US-VRAA-220054 For Healthcare Professionals The information provided in this website is intended for U.S. healthcare professionals only. I certify that I am a U.S. healthcare professional. If you choose “NO,” you will remain on the patient website. YES NO US-VRAA-220054 You are now leaving VRAYLAR.com You are leaving the VRAYLAR (cariprazine) site and connecting to a site that is not under the control of AbbVie. AbbVie is not responsible for the contents of any such site or any further links from such site, and AbbVie makes no guarantee that any such support groups will result in your desired outcome. AbbVie is providing these links to you only as a convenience and the inclusion of any link does not imply the endorsement of the linked site by AbbVie. You should also be aware that the linked site may be governed by its own set of terms and conditions and privacy policy for which AbbVie has no responsibility. Conversely, the presence of this link does not imply the linked site's endorsement of VRAYLAR.com or AbbVie. Do you wish to leave this site? YES NO US-VRA-230116test You are now leaving VRAYLAR.com You are leaving the VRAYLAR (cariprazine) site and connecting to a site that is not under the control of AbbVie. AbbVie is not responsible for the contents of any such site or any further links from such site. AbbVie is providing these links to you only as a convenience and the inclusion of any link does not imply the endorsement of the linked site by AbbVie. You should also be aware that the linked site may be governed by its own set of terms and conditions and privacy policy for which AbbVie has no responsibility. Conversely, the presence of this link does not imply the linked site's endorsement of VRAYLAR.com or AbbVie. Do you wish to leave this site? YES NO US-VRA-230180 You are now leaving VRAYLAR.com Links to other websites are provided as a service to you. AbbVie accepts no responsibility for the content of other sites. Would you like to continue? YES NO US-VRAA-220054 For Healthcare Professionals The information provided in this website is intended for U.S. healthcare professionals only. I certify that I am a U.S. healthcare professional. If you choose “NO,” you will remain on the patient website. YES NO US-VRA-230180 You are now leaving VRAYLAR.com You are leaving the VRAYLAR (cariprazine) site and connecting to a site that is not under the control of AbbVie. AbbVie is not responsible for the contents of any such site or any further links from such site. AbbVie is providing these links to you only as a convenience and the inclusion of any link does not imply the endorsement of the linked site by AbbVie. You should also be aware that the linked site may be governed by its own set of terms and conditions and privacy policy for which AbbVie has no responsibility. Conversely, the presence of this link does not imply the linked site's endorsement of VRAYLAR.com or AbbVie. Do you wish to leave this site? Yes No US-VRA-230180 For residents of Puerto Rico By selecting ‘continue’ you will enter the VRAYLAR Puerto Rico website, which includes key information presented in Spanish. Cost & Savings information on this site is intended for Puerto Rico residents only. If you are a U.S. resident looking for cost information, please select ‘Back’ and visit the Cost & Savings page. Continue Back US-VRAA-240126 US-VRA-240106 INDICATIONS AND USAGE VRAYLAR is a prescription medicine used along with antidepressant medicines to treat major depressive disorder (MDD) in adults. IMPORTANT SAFETY INFORMATION What is the most important information I should know about VRAYLAR? Elderly people with dementia-related psychosis (having lost touch with reality due to confusion and memory loss) taking medicines like VRAYLAR are at an increased risk of death. VRAYLAR is not approved for treating patients with dementia-related psychosis. IMPORTANT SAFETY INFORMATION Elderly people with dementia-related psychosis (having lost touch with reality due to confusion and memory loss) taking medicines like INDICATIONS AND USAGE VRAYLAR is a prescription medicine used along with antidepressant medicines to treat major depressive disorder (MDD) in adults. IMPORTANT SAFETY INFORMATION What is the most important information I should know about VRAYLAR? Elderly people with dementia-related psychosis (having lost touch with reality due to confusion and memory loss) taking medicines like VRAYLAR are at an increased risk of death. VRAYLAR is not approved for treating patients with dementia-related psychosis. IMPORTANT SAFETY INFORMATION Elderly people with dementia-related psychosis (having lost touch with reality due to confusion and memory loss) taking medicines like INDICATION AND USAGE VRAYLAR is a prescription medicine used along with antidepressant medicines to treat major depressive disorder (MDD) in adults. IMPORTANT SAFETY INFORMATION What is the most important information I should know about VRAYLAR? Elderly people with dementia-related psychosis (having lost touch with reality due to confusion and memory loss) taking medicines like VRAYLAR are at an increased risk of death. VRAYLAR is not approved for treating patients with dementia-related psychosis. VRAYLAR and antidepressants increase the risk of suicidal thoughts or actions in people 24 years of age and younger especially within the first few months of treatment or when the dose is changed. Depression and other mental illnesses are the most important causes of suicidal thoughts and actions. Patients on antidepressants and their families or caregivers should watch for new or worsening depression symptoms, especially sudden changes in mood, behaviors, thoughts, or feelings. This is very important when VRAYLAR or the antidepressant is started or when the dose is changed. Report any change in these symptoms immediately to the doctor. VRAYLAR may cause serious side effects, including: Stroke (cerebrovascular problems) in elderly people with dementia-related psychosis that can lead to death Neuroleptic malignant syndrome (NMS): Call your healthcare provider or go to the nearest hospital emergency room right away if you have high fever, stiff muscles, confusion, increased sweating, or changes in breathing, heart rate, and blood pressure. These can be symptoms of a rare but potentially fatal side effect called NMS. VRAYLAR should be stopped if you have NMS. Uncontrolled body movements (tardive dyskinesia or TD): VRAYLAR may cause movements that you cannot control in your face, tongue, or other body parts. Tardive dyskinesia may not go away, even if you stop taking VRAYLAR. Tardive dyskinesia may also start after you stop taking VRAYLAR. Late-occurring side effects: VRAYLAR stays in your body for a long time. Some side effects may not happen right away and can start a few weeks after starting VRAYLAR, or if your dose increases. Your healthcare provider should monitor you for side effects for several weeks after starting or increasing dose of VRAYLAR. Problems with your metabolism, such as: High blood sugar and diabetes: Increases in blood sugar can happen in some people who take VRAYLAR. Extremely high blood sugar can lead to coma or death. Your healthcare provider should check your blood sugar before or soon after starting VRAYLAR and regularly during treatment. Tell your healthcare provider if you have symptoms such as feeling very thirsty, very hungry, or sick to your stomach, urinating more than usual, feeling weak, tired, confused, or your breath smells fruity. Increased fat levels (cholesterol and triglycerides) in your blood: Your healthcare provider should check fat levels in your blood before or soon after starting VRAYLAR and during treatment. Weight gain: Weight gain has been reported with VRAYLAR. You and your healthcare provider should check your weight before and regularly during treatment. Low white blood cell count: Low white blood cell counts have been reported with antipsychotic drugs, including VRAYLAR. This may increase your risk of infection. Very low white blood cell counts, which can be fatal, have been reported with other antipsychotics. Your healthcare provider may do blood tests during the first few months of treatment with VRAYLAR. Decreased blood pressure (orthostatic hypotension): You may feel lightheaded or faint when you rise too quickly from a sitting or lying position. Falls: VRAYLAR may make you sleepy or dizzy, may cause a decrease in blood pressure when changing position (orthostatic hypotension), and can slow thinking and motor skills, which may lead to falls that can cause fractures or other injuries. Seizures (convulsions) Sleepiness, drowsiness, feeling tired, difficulty thinking and doing normal activities: Do NOT drive, operate machinery, or do other dangerous activities until you know how VRAYLAR affects you. VRAYLAR may make you drowsy. Increased body temperature: Do not become too hot or dehydrated during VRAYLAR treatment. Do not exercise too much. In hot weather, stay inside in a cool place if possible. Stay out of the sun. Do not wear too much clothing or heavy clothing. Drink plenty of water. Difficulty swallowing that can cause food or liquid to get into your lungs Who should not take VRAYLAR? Do not take VRAYLAR if you are allergic to any of its ingredients. Get emergency medical help if you are having an allergic reaction (eg, rash, itching, hives, swelling of the tongue, lip, face or throat). What should I tell my healthcare provider before taking VRAYLAR? Tell your healthcare provider about any medical conditions and if you: have or had heart problems or a stroke have or had low or high blood pressure have or had diabetes or high blood sugar in you or your family have or had high levels of total cholesterol, LDL-cholesterol, or triglycerides; or low levels of HDL-cholesterol have or had seizures (convulsions) have or had kidney or liver problems have or had low white blood cell count are pregnant or plan to become pregnant. VRAYLAR may harm your unborn baby. Taking VRAYLAR during your third trimester of pregnancy may cause your baby to have abnormal muscle movements or withdrawal symptoms after birth. Talk to your healthcare provider about the risk to your unborn baby if you take VRAYLAR during pregnancy. There is a pregnancy exposure registry for women who are exposed to VRAYLAR during pregnancy. If you become pregnant or think you are pregnant during treatment, talk to your healthcare provider about registering with the National Pregnancy Registry for Atypical Antipsychotics at 1-866-961-2388 or http://www.womensmentalhealth.org/clinical-and-research-programs/pregnancyregistry/ . are breastfeeding or plan to breastfeed. It is not known if VRAYLAR passes into breast milk. Talk to your healthcare provider about the best way to feed your baby during treatment with VRAYLAR. Tell your healthcare provider about all medicines that you take, including prescriptions, over-the-counter medicines, vitamins, and supplements. VRAYLAR may affect the way other medicines work, and other medicines may affect how VRAYLAR works. Do not start or stop any medicines while taking VRAYLAR without talking to your healthcare provider. What are the most common side effects of VRAYLAR? The most common side effects include difficulty moving or slow movements, tremors, uncontrolled body movements, restlessness and feeling like you need to move around, sleepiness, nausea, vomiting, indigestion, constipation, feeling tired, trouble sleeping, increased appetite, and dizziness. These are not all the possible side effects of VRAYLAR. VRAYLAR is available in 0.5 mg, 0.75 mg, 1.5 mg, 3 mg, 4.5 mg, and 6 mg capsules. INDICATIONS AND USAGE VRAYLAR is a prescription medicine used: along with antidepressant medicines to treat major depressive disorder (MDD) in adults to treat depressive episodes that happen with bipolar I disorder (bipolar depression) in adults to treat short-term (acute) manic or mixed episodes that happen with bipolar I disorder in adults and children ages 10 years and older Please see the full Prescribing Information , including Boxed Warnings, and Medication Guide . US-VRAA-250457 { "@context": "http://schema.org", "@type": "MedicalWebPage", "audience": "https://schema.org/Patient", "specialty": [ "https://schema.org/Psychiatric"], "url": "https://www.vraylar.com/amdd/why-vraylar", "name": "How VRAYLAR® (cariprazine) Is Thought to Work", "description": "VRAYLAR® is an add-on treatment for adults with major depressive disorder. Learn about side effects, dosing, and more. See full Prescribing Info, including Boxed Warnings.", "about": [ {"@type": "Drug", "name": "VRAYLAR®", "nonProprietaryName": "cariprazine", "description": "VRAYLAR is a prescription medicine used in adults along with antidepressant medicines to treat major depressive disorder (MDD), for short-term (acute) treatment of manic or mixed episodes that happen with bipolar I disorder, and to treat depressive episodes that happen with bipolar I (bipolar depression)", "dosageForm": "capsule", "prescribingInfo": "https://www.rxabbvie.com/pdf/vraylar_pi.pdf"}], "potentialaction": [ {"@type": "ViewAction", "name":"Connect with a healthcare provider", "description":"You’ve made progress with your antidepressant, but unresolved symptoms may leave you feeling stuck. Adding VRAYLAR can give it a lift and may help you get where you want to be.", "url":"https://www.vraylar.com/amdd/find-a-healthcare-provider"}, {"@type": "ViewAction", "name":"Create your discussion guide", "description":"Check in with yourself and create a personalized doctor discussion guide for your next appointment.", "url":"https://www.vraylar.com/doctor-discussion-guide"}, {"@type": "ViewAction", "name":"Find support and resources", "description":"Everyone’s journey with depression is different. Get helpful resources and support to help you stay on track with your prescribed treatment plan.", "url":"https://www.vraylar.com/amdd/support"}, {"@type": "ViewAction", "name":"Create your discussion guide", "description":"Check in with yourself and create a personalized doctor discussion guide for your next appointment.", "url":"https://www.vraylar.com/doctor-discussion-guide"} ], "mainEntity": [ { "@type": "Question", "name": "Have you ever tried an add-on treatment, along with your antidepressant?", "acceptedAnswer": { "@type": "Answer", "text": "Yes but I'd like to learn more about VRAYLAR, No but I'm interested in seeing how VRAYLAR may help, No but I would like to learn more about add-on treatment."}}, { "@type": "Question", "name": "What are the most common side effects of VRAYLAR?", "acceptedAnswer": { "@type": "Answer", "text": "The most common side effects include difficulty moving or slow movements, tremors, uncontrolled body movements, restlessness and feeling like you need to move around, sleepiness, nausea, vomiting, indigestion, constipation, feeling tired, trouble sleeping, increased appetite, and dizziness. Tell your healthcare provider if you have any side effect that bothers you or that does not go away. These are not all the possible side effects of VRAYLAR."}}, { "@type": "Question", "name": "Will VRAYLAR cause weight gain?", "acceptedAnswer": { "@type": "Answer", "text": "In clinical studies, 98% of patients in 6-week trials and 81% of patients in a 6-month trial had no substantial weight gain (defined by ≥7% change). In the 6-month study, the average weight gain in VRAYLAR-treated patients was 3.7 lb. Weight gain may occur. You and your doctor should monitor your weight regularly.VRAYLAR 1.5 mg/day and 3.0 mg/day."}}, { "@type": "Question", "name": "Can I anticipate any sexual side effects when adding VRAYLAR?", "acceptedAnswer": { "@type": "Answer", "text": "In clinical studies, less than 1% of patients taking VRAYLAR with their antidepressant reported sexual side effects"}} ], "video": [ {"@type": "VideoObject", "contentURL": "https://players.brightcove.net/1029485116001/Mcp9TXMkPT_default/index.html?videoId=6334113720112", "description": "Watch our TV ad and ask your provider if adding VRAYLAR to your antidepressant could help you get more symptom relief.", "duration": "T1M0S", "name": "For a lift in relief", "thumbnailURL": "https://vraylar.com/content/dam/vraylar/images/VRAA-ITS-0630/why-vraylar/video--lift-relief2.png", "transcript": "https://vraylar.com/amdd/why-vraylar/for-a-lift-in-relief-transcript", "uploadDate": "2023-10-31"}, {"@type": "VideoObject", "contentURL": "https://youtu.be/RFTAgv-seyI", "description": "Watch our TV ad and ask your provider if adding VRAYLAR to your antidepressant could help you get more symptom relief.", "duration": "T1M0S", "name": "For a lift in relief", "thumbnailURL": "https://www.vraylar.com/content/dam/vraylar/images/VRAA-ITS-0630/why-vraylar/video--lift-relief1.png", "transcript": "https://www.vraylar.com/amdd/why-vraylar/discover-a-lift-in-relief-transcript", "uploadDate": "2023-10-31"}] }